Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Competitive strengths
- Leading manufacturer of structure directing agents and phase transfer catalyst.
- Diversified product portfolio.
- Global market presence with customer base across industries.
- Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
- Experienced promoters and managers team.
- Strong financial performance track record.
Company Promoters:
Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.
Tatva Chintan Pharma Company Financial Report
| ₹ in Crores | |||
| Assets | Revenues | PAT | |
| 2018 | ₹144 | ₹137 | ₹12.29 |
| 2019 | ₹188 | ₹207 | ₹20.54 |
| 2020 | ₹249 | ₹267 | ₹37.79 |
| 2021 – 9M | ₹276 | ₹195 | ₹31.14 |
Tatva Chintan Pharma IPO Date & Price Band
| IPO Open: | 16 July 2021 |
| IPO Close: | 20 July 2021 |
| IPO Size: | Approx ₹450 Crores |
| Fresh Issue: | Approx ₹225 Crores |
| Offer for Sale: | Approx ₹225 Crores |
| Face Value: | ₹10 Per Equity Share |
| Price Band: | ₹1073 to ₹1083 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Equity: | – Shares |
| Discount: | N/A |
Tatva Chintan Pharma IPO Market Lot
The Tatva Chintan Pharma IPO minimum market lot is 13 shares with ₹14,079 application amount. The retail investors can apply up-to 13 lots with 182 shares or ₹197,106 amount.
| Minimum Lot Size: | Minimum 13 Shares |
| Minimum Amount: | ₹14,079 |
| Maximum Lot Size: | Maximum 182 Shares |
| Maximum Amount: | ₹197,106 |
Tatva Chintan Pharma IPO Allotment & Listing
The Tatva Chintan Pharma IPO date is 16 July 2021 and the close date is 20 July 2021. The allotment date is 26 July 2021 and the IPO to list on 29 July 2021.
| Basis of Allotment: | 26 July 2021 |
| Refunds: | 27 July 2021 |
| Credit to Demat Account: | 28 July 2021 |
| Listing Date: | 29 July 2021 |